NEWS > The first open big data research center on biomedical is officially set up in Shanghai

The first open big data research center on biomedical is officially set up in Shanghai

2016-03-14 09:11 | Science Network


Sponsored by East China University of Science and Technology School of Information and Metz Medicine, the theme is "Open • Link • Service" 2016 Biomedical Big Data Seminar and Huali-Metz Biomedical Open Link Big Data Research Center The inauguration ceremony was held at East China University of Science and Technology, and more than 300 experts from Fudan University, Jiaotong University-Yale University Joint Biostatistics Center, Key Laboratory of System Biology of Chinese Academy of Sciences, Shuguang Hospital, Wanda Information, universities, scientific research institutions, medical institutions and enterprises. Scholars attended the conference, focusing on big data openness and sharing, data correlation, big data key technologies and big data applications in the biomedical industry.

 

    At the same time, the research center also presented the participants with an open link data of about 1 G related to genes, drugs and diseases based on the RDF (Resource Definition Framework) format (Linked  ;Open Data) collection. In the Internet+ era, big data is considered to be a key node for changing the industry, and the biomedical industry is no exception.  
According to the teacher of East China University of Science and Technology, in recent years, the massive data of the biomedical industry has rapidly formed, but compared with the large number of open link datasets abroad, the research and development of biomedical research, domestic biology The data of the medical industry is closed, scattered and inconsistent, which restricts the development of the entire industry. To this end, the School of Information, East China University of Science and Technology, together with Shanghai Metz Medical, under the guidance of the Shanghai Economic and Information Technology Commission and the support of the Shanghai Big Data Alliance, established the “Biomedical Open Link Big Data Joint Research Center”. The aim is to give full play to the advantages of both parties, provide open Chinese basic biomedical data, correlate existing biomedical open link data at home and abroad, build a public service platform for biomedical big data research, and provide more support for biomedical big data mining. and service.

    “The marriage of medical big data and precision medicine provides a feasible way to achieve accurate prevention, precise treatment and accurate prognosis of health care. & rdquo; Vice President Liu Changsheng of East China University of Science and Technology said that in recent years, the massive data of the biomedical industry has rapidly formed. At the same time, with the development of key technologies for big data processing and data opening, big data will play a role in promoting the development of the industry. Important role. Zhang Fabao, chairman of Metz Medical, believes that the current development of health information technology is developing rapidly. The industry-related data related to medicine is growing at an unprecedented rate. Big data applications have also started. The research on open medical big data has become a hot spot. Some international Famous universities set up big data research institutions, but they still face many problems that need to be solved in many aspects such as data utilization and technology application. According to reports, biomedical big data mining is an interdisciplinary subject between biomedicine and information technology.

    In terms of big data mining, East China University of Science and Technology has the advantages of computer science, mathematics and statistics, and the student team won the first prize of 2014 Baidu Knowledge Mapping Data Analysis Competition, 2015 Baidu Big Data Competition first prize and special contribution award, and won the 2015 linguistic link open data competition held in Spain. At present, East China University of Science and Technology is cooperating with Shuguang Hospital, Wanda Information, and Shanghai Shenkang to jointly undertake the National 863 Program “Clinical Diseases and Tumor Diseases in Chinese and Western Medicine Clinical Big Data Processing Analysis and Applied Research”. East China University of Science and Technology has also achieved a series of achievements in the field of biomedical research. The number of research papers published in the top journals of medicinal chemistry & mdash;— American Journal of Medicinal Chemistry is also ahead of other universities in China. According to the number of papers published, in the field of Top10 research institutions, it ranks third with Purdue University in the field of “structure-based drug design”. Shanghai Meisi Pharmaceutical Technology Co., Ltd., as the largest pharmaceutical biomedical and medical health industry service platform in China, provides professional medical bioinformatics services, clinical medical research assistance services, and clinical research results transformation services. In particular, it has core resources in the medical field and a strong academic team in the field of clinical medicine.

It is reported that the Huali-Metz Biomedical Big Data Research Center will carry out related research to further promote the development of biomedical big data from the aspects of open link big data and focusing on diversified development models. Through Open Link Big Data  Implement & Openquo;link•service”. Based on the basic knowledge map, providing technical services such as data download, browsing, query, question and answer, semantic annotation, etc., and on the basis of this, provide electronic medical record data quality testing, disease classification, drug component query and other business services. Provide health guidance to the public and provide professional information services for medical and pharmaceutical companies. In the next three years, it will provide supplementary decision-making consulting services for the government public health system, and provide hospitals and pharmaceutical companies with inquiry services and auxiliary treatment services such as disease knowledge bases and drug knowledge bases. Through sharing and feedback, we will promote the update and development of the knowledge base, relying on the Shanghai Big Data Industry Innovation Alliance and the Zhongguancun Big Data Alliance to unite various medical institutions and IT organizations to form a biomedical open big data community, and gradually realize “open” • Link • Service & rdquo; service concept. Focus on diversified development models to accelerate biomedical big data innovation. Heterogeneous data extraction, integration, processing technology, knowledge mapping technology, semantic annotation technology, medical big data mining technology research and algorithm parallelization technology, semantic quality control technology and other key technologies in the field of biomedicine are studied. Through the construction of the innovation base, the problems of the existing system closure and resource dispersion will be effectively solved, and the rapid transformation and diffusion of the results will be greatly improved.